Cellular Zoomer: A Clinical Case Report

This case simulation—grounded in patterns observed across hundreds of clinical consultations—is designed to support evidence-informed interpretation of the Cellular Zoomer Sample Report.

Clinical Narrative

A 48-year-old male endurance athlete presents with declining recovery and performance despite consistent training (10–12 hours/week) and stable nutrition.

Over the past year, he reports:

• Reduced tolerance to interval training
• Prolonged muscle soreness
• Declining aerobic endurance
• Afternoon fatigue and non-restorative sleep
• Increased frequency of minor respiratory infections

Routine labs (CBC, CMP, thyroid, testosterone, ferritin, inflammatory markers) were within normal limits.

Given concern for cellular metabolic dysfunction and exercise-induced oxidative stress, advanced testing with the Cellular Zoomer (Organic Acids + Oxidative Stress Panel) was performed.

Clinical Questions

Do cellular biomarkers reveal mechanisms contributing to impaired recovery and performance, including:

• Mitochondrial dysfunction
• Impaired fatty acid oxidation
• Oxidative stress burden
• Microbial dysbiosis

Key Laboratory Findings

1. Increased Amino Acid Metabolism

• 2-Oxoisovaleric Acid: 3.4 mmol/mol ↑

• 3-Methyl-2-oxovaleric Acid: 3.1 mmol/mol ↑

• 4-Hydroxyphenyllactic Acid: 22 mmol/mol ↑
• Phenyllactic Acid: 0.48 mmol/mol ↑

Interpretation

The combined elevation of these markers suggests increased amino acid catabolism involving both branched-chain and aromatic amino acids.

2-Oxoisovaleric acid and 3-methyl-2-oxovaleric acid are intermediates of branched-chain amino acid metabolism, while 4-hydroxyphenyllactic acid and phenyllactic acid are associated with tyrosine and phenylalanine metabolism, respectively.

In an athlete, this pattern may occur with high training load, inadequate caloric or carbohydrate availability, or insufficient recovery, when amino acids are increasingly utilized as substrates for energy metabolism. Persistent elevations may therefore indicate increased metabolic demand and protein turnover associated with training stress.

The elevations in 4-hydroxyphenyllactic and phenyllactic acids may also have a microbial contribution, as intestinal bacteria can metabolize aromatic amino acids into these compounds. When other evidence of dysbiosis or impaired gut function is present, the pattern may therefore represent a combination of increased host amino acid turnover and altered microbial aromatic amino acid metabolism, rather than training stress alone.

2. Mitochondrial Dysfunction & Glycolytic Shift

• 3-Hydroxyglutaric Acid: 7.9 mmol/mol ↑

• 3-Methylglutaconic Acid: 8.6 mmol/mol ↑

• Lactic Acid: 64 mmol/mol ↑

• Cis-aconitic Acid: 29.92 ↑

Interpretation

This combined pattern suggests altered mitochondrial energy metabolism with impaired TCA cycle efficiency and increased reliance on glycolysis.

3-Hydroxyglutaric acid and 3-methylglutaconic acid elevations can be associated with disturbances in mitochondrial metabolic pathways and membrane-related energy metabolism.

Cis-aconitic acid is a TCA cycle intermediate formed between citrate and isocitrate; its elevation may indicate altered TCA cycle flux, including a potential bottleneck around aconitase activity. Aconitase contains an iron-sulfur cluster and is particularly sensitive to oxidative stress, making this finding potentially relevant when other markers of oxidative stress or mitochondrial dysfunction are also abnormal.

Elevated lactic acid indicates increased conversion of pyruvate to lactate and may reflect greater reliance on glycolytic ATP production relative to mitochondrial oxidative metabolism. In an endurance athlete, this pattern may be associated with:

• Reduced aerobic efficiency
• Earlier lactate accumulation during exercise
• Reduced mitochondrial ATP production
• Increased susceptibility to fatigue
• Decreased endurance and recovery capacity

Clinical relevance:

The combination of elevated lactate with abnormal mitochondrial/TCA-cycle metabolites is more informative than lactate alone, as it supports investigating factors that may impair mitochondrial function, including high training load, inadequate recovery or fueling, oxidative stress, and micronutrient insufficiencies involved in mitochondrial energy metabolism.

3. Impaired Fatty Acid Oxidation

Elevations in adipic, suberic, and ethylmalonic acids suggest compensatory omega-oxidation, indicating inefficient mitochondrial β-oxidation.

Clinical relevance:

• Reduced fat utilization during endurance exercise

• Increased fatigue during prolonged activity
  

4. Oxidative Stress & Glutathione Depletion

• Pyroglutamic Acid: 41 mmol/mol ↑

• 2-Hydroxybutyric Acid: 2.6 mmol/mol ↑

Interpretation

Elevated pyroglutamic acid indicates increased glutathione turnover, suggesting depletion of the body’s primary intracellular antioxidant system. Increased 2-hydroxybutyric acid reflects increased demand for glutathione synthesis during oxidative stress.

These findings suggest that the patient’s antioxidant defenses may be overwhelmed by metabolic and exercise-related oxidative stress.

5. Microbial Dysbiosis

• DHPPA: 0.72 mmol/mol ↑
• Hippuric Acid: 720 mmol/mol ↑
• 4-Hydroxyphenylacetic Acid: 22 mmol/mol ↑

Interpretation

The combined elevation of these microbial-associated metabolites suggests altered intestinal microbial metabolism and possible dysbiosis.

In endurance athletes, repeated GI hypoperfusion, training stress, and dietary factors can alter the gut microbiome and intestinal barrier. This pattern may contribute to increased intestinal permeability, systemic inflammation, oxidative stress, and impaired recovery.

Microbial dysbiosis may contribute to intestinal permeability, systemic inflammation, and/or increased oxidative stress. 

6. Lipid Peroxidation Markers

• 8-iso-Prostaglandin F2α: 0.48 µg/g ↑
  Malondialdehyde: 168.4 µmol/g ↑

Interpretation

These markers reflect oxidative damage to cellular membranes. Increased lipid peroxidation is commonly observed in endurance athletes experiencing high mitochondrial reactive oxygen species production during prolonged aerobic activity.

Oxidative damage to mitochondrial membranes can impair electron transport chain efficiency and ATP generation.

7. DNA and RNA Oxidative Damage

• 8-Hydroxy-2-deoxyguanosine (8-OHdG): 11.6 µg/g ↑

• 8-Hydroxyguanosine: 97.89 µg/g ↑

Interpretation

Elevated nucleic acid oxidation markers indicate oxidative damage affecting both nuclear and mitochondrial DNA. Mitochondrial DNA is particularly vulnerable to oxidative injury due to its proximity to the electron transport chain.

Damage to mitochondrial DNA can impair mitochondrial replication and reduce energy production efficiency.

8. Protein Oxidation and Glycoxidation

• 3-Bromotyrosine: 362.78 nmol/mg ↑

• Nε-Carboxyethyllysine (CEL): 93.45 µg/g ↑

Interpretation

These markers indicate oxidative modification of proteins and glycation-related oxidative damage. Oxidative protein modification can impair enzyme function, particularly enzymes involved in mitochondrial metabolism and muscle repair.

9. Oxidative Damage Score

The Oxidative Stress Profile also generates an estimated physiological oxidative age by comparing the patient’s oxidative damage markers to age-matched population distributions. In this case, the patient’s chronological age is 48 years, while the pattern of elevated lipid peroxidation, nucleic acid oxidation, and glycoxidative damage corresponds to an estimated physiological oxidative age of approximately 84 years. This suggests a higher cumulative burden of oxidative stress than typically observed in individuals of similar chronological age.

For endurance athletes, this pattern can emerge when repeated high training loads, insufficient recovery, mitochondrial metabolic strain, and antioxidant depletion collectively increase reactive oxygen species production. The oxidative age estimate therefore provides a useful integrative indicator of systemic oxidative damage and supports the clinical picture of impaired recovery and metabolic stress observed in this patient.

Integrated Clinical Insights

This case reveals a multi-system pattern of cellular stress not captured by conventional testing:

• Mitochondrial dysfunction with reduced ATP efficiency
• Impaired fatty acid oxidation limiting endurance fuel utilization
• Elevated oxidative stress with glutathione depletion
• Gut dysbiosis contributing to systemic inflammation

Together, these findings explain the patient’s:

• Declining endurance performance
• Prolonged recovery
• Increased fatigue and illness susceptibility
  
  

Clinical Applications

Interventions should target mitochondrial efficiency, redox balance, and metabolic flexibility.

Nutrition Strategies

• Increasing intake of polyphenol-rich foods such as berries, pomegranate, and green tea

• Emphasizing dietary omega-3 fatty acids from fatty fish, flaxseed, and walnuts

• Ensuring adequate protein intake (1.6–1.8 g/kg/day) to support recovery and mitochondrial enzyme synthesis

• Increasing consumption of leafy greens and cruciferous vegetables to support antioxidant pathways and detoxification

Targeted Supplement Support

• Mitochondrial support: CoQ10, riboflavin, magnesium
• Antioxidant support: NAC, vitamin C, alpha-lipoic acid, selenium
• Fatty acid metabolism: Acetyl-L-carnitine, omega-3s

Training Modifications

• Increase Zone 2 aerobic training
• Reduce high-intensity frequency temporarily
• Incorporate structured recovery and HRV monitoring

Recovery Optimization

• Prioritize 7–9 hours of sleep
• Address psychosocial stress
• Consider advanced recovery modalities where appropriate
  
  

Follow-Up

Repeat testing in 8–12 weeks may help assess improvements in:

• Mitochondrial metabolism
• Oxidative stress markers
• Microbial metabolites
  
  

Synergistic Testing

• Gut Zoomer
• Nutrient Zoomer
• Toxin Zoomer